Farsin Yadegardjam

COI Partners AG (COI Partners) is a private equity firm founded in 2000. The firm is headquartered in Zurich.

Phenex Pharmaceuticals AG engages in the research and development of small molecule drugs focusing on the identification and analysis of selective drug candidates that target nuclear receptors. It also offers its resources and capabilities in the field of nuclear receptors to customers in the pharmaceutical and other life science industries. The company was founded by Claus Kremoser in 2002 and is headquartered in Ludwigshafen, Germany.

EUROIMMUN Medizinische Labordiagnostika AG is a holding company, which engages in the development and production of test systems and automation solutions for the laboratory diagnosis of autoimmune and infectious diseases, allergies, and gene analyses. The company was founded by Winfried Stöcker in September 1987 and is headquartered in Luebeck, Germany.

COI Partners AG (COI Partners) is a private equity firm founded in 2000. The firm is headquartered in Zurich.

COI Partners AG (COI Partners) is a private equity firm founded in 2000. The firm is headquartered in Zurich.

COI Partners AG (COI Partners) is a private equity firm founded in 2000. The firm is headquartered in Zurich.

Phenex Pharmaceuticals AG engages in the research and development of small molecule drugs focusing on the identification and analysis of selective drug candidates that target nuclear receptors. It also offers its resources and capabilities in the field of nuclear receptors to customers in the pharmaceutical and other life science industries. The company was founded by Claus Kremoser in 2002 and is headquartered in Ludwigshafen, Germany.

Part of Arkema SA, SDP Holding NV is an investment holding Belgian company. The company is based in Nazareth, Belgium. SDP Holding was founded in 2018.

Part of Arkema SA, SDP Holding NV is an investment holding Belgian company. The company is based in Nazareth, Belgium. SDP Holding was founded in 2018.

K & K Group AG operates as a holding Swiss company. The private company is based in Zug, CH. and has subsidiaries in Switzerland, United Kingdom and Germany.

Part of Arkema SA, SDP Holding NV is an investment holding Belgian company. The company is based in Nazareth, Belgium. SDP Holding was founded in 2018.

Part of Arkema SA, SDP Holding NV is an investment holding Belgian company. The company is based in Nazareth, Belgium. SDP Holding was founded in 2018.

Part of Arkema SA, SDP Holding NV is an investment holding Belgian company. The company is based in Nazareth, Belgium. SDP Holding was founded in 2018.

Part of Arkema SA, SDP Holding NV is an investment holding Belgian company. The company is based in Nazareth, Belgium. SDP Holding was founded in 2018.

Phenex Pharmaceuticals AG engages in the research and development of small molecule drugs focusing on the identification and analysis of selective drug candidates that target nuclear receptors. It also offers its resources and capabilities in the field of nuclear receptors to customers in the pharmaceutical and other life science industries. The company was founded by Claus Kremoser in 2002 and is headquartered in Ludwigshafen, Germany.

Phenex Pharmaceuticals AG engages in the research and development of small molecule drugs focusing on the identification and analysis of selective drug candidates that target nuclear receptors. It also offers its resources and capabilities in the field of nuclear receptors to customers in the pharmaceutical and other life science industries. The company was founded by Claus Kremoser in 2002 and is headquartered in Ludwigshafen, Germany.

COI Partners AG (COI Partners) is a private equity firm founded in 2000. The firm is headquartered in Zurich.

COI Partners AG (COI Partners) is a private equity firm founded in 2000. The firm is headquartered in Zurich.

COI Partners AG (COI Partners) is a private equity firm founded in 2000. The firm is headquartered in Zurich.

COI Partners AG (COI Partners) is a private equity firm founded in 2000. The firm is headquartered in Zurich.

GENEART AG provides integrated system solutions for DNA engineering focusing on gene synthesis, evolution and plasmid services. The company provides the technologies for pharmaceutical and biotechnology companies, chemical industry and universities for the development and production of new bio therapeutics, vaccines and improved industrial enzymes. Its service portfolio is comprised of 4 fields of business, which range from the production of synthetic genes and the generation of gene variants/gene libraries in combinatorial biology right through to the production of plasmid DNA. The company was founded by Ralf Wagner and Marcus Graf in 1999 and is headquartered in Regensburg, Germany.

Phenex Pharmaceuticals AG engages in the research and development of small molecule drugs focusing on the identification and analysis of selective drug candidates that target nuclear receptors. It also offers its resources and capabilities in the field of nuclear receptors to customers in the pharmaceutical and other life science industries. The company was founded by Claus Kremoser in 2002 and is headquartered in Ludwigshafen, Germany.

GENEART AG provides integrated system solutions for DNA engineering focusing on gene synthesis, evolution and plasmid services. The company provides the technologies for pharmaceutical and biotechnology companies, chemical industry and universities for the development and production of new bio therapeutics, vaccines and improved industrial enzymes. Its service portfolio is comprised of 4 fields of business, which range from the production of synthetic genes and the generation of gene variants/gene libraries in combinatorial biology right through to the production of plasmid DNA. The company was founded by Ralf Wagner and Marcus Graf in 1999 and is headquartered in Regensburg, Germany.

Phenex Pharmaceuticals AG engages in the research and development of small molecule drugs focusing on the identification and analysis of selective drug candidates that target nuclear receptors. It also offers its resources and capabilities in the field of nuclear receptors to customers in the pharmaceutical and other life science industries. The company was founded by Claus Kremoser in 2002 and is headquartered in Ludwigshafen, Germany.

Part of Arkema SA, SDP Holding NV is an investment holding Belgian company. The company is based in Nazareth, Belgium. SDP Holding was founded in 2018.

Phenex Pharmaceuticals AG engages in the research and development of small molecule drugs focusing on the identification and analysis of selective drug candidates that target nuclear receptors. It also offers its resources and capabilities in the field of nuclear receptors to customers in the pharmaceutical and other life science industries. The company was founded by Claus Kremoser in 2002 and is headquartered in Ludwigshafen, Germany.

GENEART AG provides integrated system solutions for DNA engineering focusing on gene synthesis, evolution and plasmid services. The company provides the technologies for pharmaceutical and biotechnology companies, chemical industry and universities for the development and production of new bio therapeutics, vaccines and improved industrial enzymes. Its service portfolio is comprised of 4 fields of business, which range from the production of synthetic genes and the generation of gene variants/gene libraries in combinatorial biology right through to the production of plasmid DNA. The company was founded by Ralf Wagner and Marcus Graf in 1999 and is headquartered in Regensburg, Germany.

EUROIMMUN Medizinische Labordiagnostika AG is a holding company, which engages in the development and production of test systems and automation solutions for the laboratory diagnosis of autoimmune and infectious diseases, allergies, and gene analyses. The company was founded by Winfried Stöcker in September 1987 and is headquartered in Luebeck, Germany.